Risk Resilience: Bawn's Guide to Cybersecurity and Beyond

The High Cost of Non-Compliance: Lessons from a Supplement CEO’s Downfall

Written by Bawn | Mar 11, 2025 1:15:00 PM

Regulatory compliance isn't just about avoiding fines—it's about protecting your business, your customers, and your reputation. When companies cut corners on compliance, they risk financial disaster, legal trouble, and even criminal charges.

One of the most extreme cases of non-compliance in recent history involved Steven Warshak, the founder of Berkeley Premium Nutraceuticals, a Cincinnati-based supplement company best known for selling Enzyte, a so-called “natural male enhancement” pill. His aggressive marketing tactics and disregard for consumer protection laws led to a massive federal investigation, a high-profile criminal trial, and a 10-year prison sentence.

His story serves as a stark warning for business owners in all industries—especially those handling sensitive customer transactions, data, and financial processes.

A Business Built on Deception

Warshak’s company grew rapidly through aggressive advertising, including exaggerated claims about Enzyte’s effectiveness and a widely recognized (yet misleading) marketing campaign. But the real problem wasn’t just the marketing—it was the business model.

Like many companies using “free trial” offers, Berkeley Premium Nutraceuticals automatically enrolled customers in recurring billing plans. Customers who signed up for a free sample often found themselves locked into ongoing charges that were difficult, if not impossible, to cancel.

As complaints mounted, banks and credit card companies flagged the company due to an abnormally high number of chargebacks. This put Berkeley Premium Nutraceuticals on the radar of regulators, leading to an extensive investigation by the Federal Trade Commission (FTC) and federal prosecutors.

Regulators Step In

What began as a flood of consumer complaints soon turned into a full-blown criminal case. In 2006, Warshak and several company executives were indicted on 112 counts, including conspiracy, fraud, and money laundering. The company had processed more than $100 million in unauthorized credit card charges, misleading thousands of consumers.

The consequences were severe. The FTC successfully shut down Berkeley Premium Nutraceuticals, and in 2008, Warshak was convicted on multiple counts of fraud. He was originally sentenced to 25 years in prison, later reduced to 10 years. He was released in 2017, but his company, fortune, and reputation were permanently destroyed.

The Compliance Lessons Every Business Should Learn

Warshak’s downfall wasn’t just a result of bad luck—it was the inevitable consequence of ignoring regulatory compliance. Here’s what every business leader should take away from this case:

1. Transparency Is Critical

Customers have a right to know exactly what they’re signing up for. If your business relies on automatic billing, subscription models, or complex terms, clear disclosures are non-negotiable. The FTC actively enforces laws against deceptive practices, and non-compliance can lead to lawsuits, hefty fines, or worse.

2. Chargebacks Are a Warning Sign

A high rate of chargebacks signals that customers feel misled or overcharged. This doesn’t just hurt your ability to process payments—it raises red flags for banks, payment processors, and regulators. Businesses with high chargeback rates are often classified as “high-risk,” leading to frozen accounts, increased fees, or being blacklisted by major financial institutions.

3. Data and Financial Security Matter

Fraudulent billing practices aren’t just an FTC issue—they can also trigger criminal investigations for wire fraud and money laundering. Ensuring your payment systems are compliant with industry regulations like PCI DSS (Payment Card Industry Data Security Standard) is essential to avoiding legal trouble.

4. Regulatory Scrutiny Isn’t Just for Big Businesses

Many companies assume they’re too small for regulators to care about. But agencies like the FTC, SEC, and DOJ regularly investigate businesses of all sizes—especially in industries prone to consumer complaints, such as financial services, healthcare, and e-commerce.

5. Leadership Accountability Is Real

Warshak’s case proves that executives can be held personally liable for regulatory violations. Ignorance is not a defense. Business owners and executives must stay informed about compliance requirements and ensure their teams follow the law.

Final Thoughts: The Cost of Non-Compliance Is Too High

Steven Warshak’s downfall is a cautionary tale about the dangers of prioritizing short-term profit over regulatory compliance. While his company’s marketing tactics may have been effective at driving sales, they ultimately led to criminal charges, financial ruin, and years behind bars.

At Bawn, we help businesses navigate complex compliance landscapes, ensuring they operate ethically and securely. Whether you’re dealing with data protection, payment security, or industry regulations, we provide expert guidance to keep you on the right side of the law—while protecting your customers and your bottom line.

Don’t let compliance be an afterthought. If your company needs guidance on security and regulatory risk, reach out to Bawn today.